| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |